Inside the Investment Committee: A Real Healthtech Deal Debate
Webinar Overview
Most healthtech startups sound compelling on paper. Fewer hold up in the real world.
In this session, you’ll get a behind-the-scenes look at how healthcare investors and physicians evaluate an actual opportunity that went through our investment committee.
We’ll walk through the company, the problem it’s solving, and most importantly, the discussion that followed. Where we leaned in, where we pushed back, and the questions that ultimately matter when deciding whether something will actually get used in practice.
What You’ll See
A real (anonymized) healthtech deal presented the way we reviewed it internally
The key questions we ask before making an investment
Where clinical and operational insight changes the conversation
How we think about workflow fit, adoption, and risk in healthcare
Who This Is For
Physicians and clinicians interested in healthcare innovation
Healthcare professionals who want to better understand how new technologies are evaluated
Operators and leaders curious how investment decisions are made behind the scenes
Why This is Different
This is not a pitch. And it’s not a theoretical framework.
You’ll see how a real decision gets worked through, including the uncertainty, tradeoffs, and debates.
If you’ve ever looked at a new technology and wondered, “Would this actually work where I practice?” this session is for you.
This session will be recorded. If you can't make it live, RSVP anyway to receive the recording.
About the Speakers
Paul Slosar, MD, MHCDS is an orthopedic spine surgeon who practiced for 28 years, including 13 years as president and administrative partner, in the San Francisco Bay area. Dr. Slosar also has extensive experience as a Health Tech operator and advisor with multiple successful exits. He currently works full-time as a med-tech executive and strategic consultant for healthcare companies. Dr. Slosar holds a Master of Health Care Delivery Science from Dartmouth College, an MD from Rush University, and an Intensive Seminar Certificate in Value-Based Health Care from Harvard Business School.
Vipul Kella, MD is a board-certified emergency physician who has been practicing for two decades in the Washington D.C. area. He has spent over a decade as a hospital executive, focusing on innovations in quality improvement and patient safety. He has consulted with several Fortune 500 companies and hospital systems in areas of operational improvement and healthcare strategy. He is currently the Chief Medical Officer of a pre-market wearables company in the remote physiological monitoring (RPM) space.
Tracy Poole is an attorney with over 30 years of experience in complex commercial transactions, M&A, financing, energy, hedge fund and venture capital disciplines. Tracy was corporate and outside counsel to leading energy marketing and trading companies and helped close some of the largest wholesale energy transactions in existence. He is the former General Counsel of a large energy-related hedge fund and the founder and operator of an independent upstream oil and gas producer with multiple exits. Tracy has been investing in early-stage companies for more than 20 years.